PDB9 Budget IMPACT Analysis of Empagliflozin in Type-2 Diabetes Patients with High Cardiovascular Risk in South Korea Based on Empa-REG OUTCOME® Trial: HIRA(HEALTH INSURANCE REVIEW & ASSESSMENT SERVICE)-NPS (NATIONAL PATIENTS SAMPLE) Database
Keyword(s):
2018 ◽
Vol Volume 10
◽
pp. 791-803
◽
Keyword(s):
2019 ◽
Vol 4
(2)
◽
pp. 321-330
◽
Keyword(s):
Keyword(s):
Keyword(s):